Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

In furtherance of our intimation dated 25th May, 2022 and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of the Postal Ballot Notice. In compliance with the relevant circulars issued by Ministry of Corporate Affairs, the said Notice has already been sent through electronic mode to those members whose e-mail IDs are registered with the Company/ Depositories as on Friday, 20th May 2022, being the cut-off date. The Company has engaged CDSL to provide e-Voting facility to its members. The e-Voting period commences on Wednesday, 0151 June, 2022 from 9:00 A.M. (IST) and ends on Thursday, 30th June, 2022 at 5:00 P.M. (1ST). Please note that communication of assent or dissent of the members would only take place through thee-Voting. The instructions for remote e-Voting are provided in the Postal Ballot Notice.
30-05-2022

Buy Torrent Pharmaceuticals; target of Rs 3235: ICICI Direct

ICICI Direct is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 3235 in its research report dated May 26, 2022.
30-05-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2022
30-05-2022
Bigul

Why you should accumulate shares of Torrent Pharma

A larger part of the business is geared for growth and now at fair valuation
28-05-2022

Torrent Pharma acquires four therapy segment brands from Dr Reddy's

Styptovit-E, a gynaecology product, has an estimated market size of roughly Rs 500 crore, according to data from AIOCD, a pharmaceutical market research company
26-05-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Torrent Pharma acquires 4 Brands from Dr. Reddy's laboratories
26-05-2022

Earnings Call for Q4FY22 of Torrent Pharmaceuticals

Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
25-05-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call Wit''1 Analysts / Investors On Audited Financial Results For The Quarter And Year Ended 31St March, 2022

In continuation of our letter dated 20-May-22 and pm''suant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirem??nts) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2022, has been placed on the Company''s website at https://torrentpharma.com/pdf/investors/Audio_Recording31032022.mp3
25-05-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Board recommends Bonus Issue

Torrent Pharmaceuticals Ltd has informed BSE that the Board has at its meeting held on May 25, 2022, approved / recommended, inter alia, the following: - Issue of Bonus shares in the ratio of 1:1 i.e. one equity share for each fully paid up equity share held as on record date fixed for the purpose. Consequent to the bonus issue, the total paid up share capital will be Rs. 169.22 Crores from the existing Rs. 84.62 Crores. The bonus issue of equity shares is subject to the approval of the members through Postal Ballot and any other applicable statutory and regulatory approvals, as may be required.
25-05-2022
Next Page
Close

Let's Open Free Demat Account